ACE2 and COVID-19: reported upregulation of proinflammatory markers CCR2, DPP9, HSPAIL, TYK2, OAS1, ACE2, and TMPRSS2 in brain tissues of alcohol use disorder patients who died while hospitalized with severe COVID-19 outcomes as compared to non-alcohol using patients [32].